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Summary
QUESTIONS UNDER STUDY: The starting point of the
interdisciplinary project “Assessing the impact of diagnosis
related groups (DRGs) on patient care and professional
practice” (IDoC) was the lack of a systematic ethical as-
sessment for the introduction of cost containment measures
in healthcare. Our aim was to contribute to the methodolo-
gical and empirical basis of such an assessment.
METHODS: Five sub-groups conducted separate but re-
lated research within the fields of biomedical ethics, law,
nursing sciences and health services, applying a number of
complementary methodological approaches. The individu-
al research projects were framed within an overall ethic-
al matrix. Workshops and bilateral meetings were held to
identify and elaborate joint research themes.
RESULTS: Four common, ethically relevant themes
emerged in the results of the studies across sub-groups: (1.)
the quality and safety of patient care, (2.) the state of pro-
fessional practice of physicians and nurses, (3.) changes
in incentives structure, (4.) vulnerable groups and access
to healthcare services. Furthermore, much-needed data for
future comparative research has been collected and some
early insights into the potential impact of DRGs are out-
lined.
CONCLUSIONS: Based on the joint results we developed
preliminary recommendations related to conceptual analys-
is, methodological refinement, monitoring and implement-
ation.
Key words: diagnosis related groups (DRG), cost
containment, ethics, interdisciplinary research, healthcare
reform, Switzerland
Introduction
Background to healthcare reforms, cost containment
and DRGs
Cost containment is a major concern for contemporary
healthcare systems that aim to sustain affordable healthcare
of good quality. Many countries are therefore in the process
of restructuring healthcare towards more efficient and eco-
nomically viable systems. One of the mechanisms to in-
centivise the efficient delivery of healthcare is the intro-
duction of a payment system based on diagnosis-related
groups (DRGs). DRGs were first introduced as a payment
system for Medicare in the USA in 1983, and are being in-
creasingly implemented worldwide [1]. If the DRG system
is used as the basis for reimbursement – and not only for
classifying cases –, payment is effected according to a pro-
spectively calculated standard amount per case, rather than,
for example, fee-for-service or per diem payment [2–4].
Swiss acute-care hospitals were required to implement a
DRG-based prospective reimbursement system for in-pa-
tient hospital care from 2012 on as part of a wider health-
care reform in Switzerland [5]1. In the literature, the ad-
vantages of introducing DRGs are described as an increase
in the transparency of hospital services, an incentive for the
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efficient delivery of appropriate care, cost containment and
the improvement of the quality of care [6–8].
However, from the outset of DRG implementation, con-
cerns have been raised about how DRGs might influence
aspects of healthcare delivery such as the quality of patient
care, access to care and professional practice. For example,
DRGs could encourage hospitals to admit more cost-effect-
ive patients on average, while hindering access for patients
who are likely to cost more than is typical for their diagnos-
is [2, 9, 10]. The potential negative impact of DRGs on the
working environment and professional standards of health-
care practitioners, such as nurses and physicians, has also
been considered: the financial incentives implicit in DRGs
could contradict the ethical standards and responsibilities
of nurses and physicians [11–13]. Questions have also been
raised about whether DRGs are achieving their often stated
aims as some studies express doubts about whether DRG-
based systems actually help to contain costs [6].
From our point of view, successful healthcare reforms
should not only be judged according to whether or not
they contain costs but also according to any additional im-
pact they might make on healthcare, be it at the level of
population health, at the level of hospital management or
at the level of individual healthcare settings. However, in
most cases there is no comprehensive assessment of the im-
pact of healthcare reforms on cost, quality and access to
care, nor on the professional standards of healthcare prac-
titioners. This is particularly striking given that there are
well-elaborated international standards to evaluate risks,
benefits and cost-effectiveness of pharmaceuticals, and that
healthcare reforms arguably have an even larger impact on
public health than pharmaceuticals do [14–16]. In addi-
tion, the implementation of DRGs particularly has not been
considered according to a systematic ethical framework,
neither in Switzerland nor elsewhere [17].
In the wider context of changes in Swiss health policy, the
DRG-based payment system and accompanying reforms
have been implemented in a healthcare system with high
patient satisfaction, which however, the OECD has de-
scribed as having “a poor health information system”, and
which requires better monitoring and reporting of quality
of care in hospitals [18]. Despite these problems and even
though in 2011 the OECD called for an improvement in
cost containment in Switzerland, its health care system has
been ranked as one of the best worldwide [19]. Due to
its superior performance, the Swiss healthcare system has
been considered as a possible model for other countries
[20, 21]. If Switzerland succeeds in systematically assess-
ing the impact of the introduction of DRGs, this assessment
could also provide a model for evaluating cost containment
reforms in other countries.
The IDoC project
The starting point of our interdisciplinary IDoC project,
“Assessing the impact of diagnosis related groups (DRGs)
on patient care and professional practice”2, was the lack
of a systematic assessment of the introduction of cost con-
tainment measures in healthcare in general. Our aim was to
provide a pioneering model for such an assessment, and we
chose to study the example of DRGs, as they were about to
be introduced in Switzerland. Our research consisted of (1.)
providing a systematic ethical framework for our research,
(2.) developing elements of tools for future use in monit-
oring the impact of DRGs, and (3.) performing empirical
research on the impact of DRGs from various perspectives.
Since significant ethical values underlie cost containment,
quality of and access to care, and professional practice, the
overall context for the project was set by the discipline of
biomedical ethics. However, we explicitly aimed to benefit
from the resulting synergies of the different disciplines in-
volved (medical ethics, law, nursing science and health ser-
vices research) [4, 22]. Such a far-reaching reform of the
healthcare system, as it took place in Switzerland, is bound
to have multiple effects. By adopting an interdisciplinary
approach we aimed to avoid jumping to conclusions based
on results in one area only. Instead, our project was deve-
loped in order to consider a wider array of parameters than
standard approaches and to place these results within an
ethical context.
To develop such a multidisciplinary project, and to perform
empirical research on isolated elements of complex
changes in healthcare – the introduction of DRGs was only
one of several aspects of the healthcare reform in Switzer-
land – is challenging on many levels [4]. One of the prin-
cipal challenges is to deal with the difficulty of causal attri-
butions between changes in healthcare and the introduction
of particular measures, such as DRGs, especially in such
a short period of study – only three years3. Even though
we provide some empirical data on the years 2011–2013
our primary aim for the IDoC study was therefore not to
provide a comprehensive empirical assessment of the ef-
fects of DRGs, as this would have required a longitudin-
al study over a longer time span. However, these limits in
terms of empirical results, and which are prevalent in much
of the literature, are precisely part of the reason why we
have developed a framework for understanding how specif-
ic and isolated results should be understood within a wider
research, policy and ethical context.
While individual papers have been published by the sub-
groups during the course of the study, this paper intends to
provide an overview of the results and recommendations of
the IDoC project as a whole.
The five sub-projects included the disciplines of Biomedic-
al Ethics (Project Leaders (PL): Nikola Biller-Andorno and
Verina Wild, University of Zurich), Law (PL: Bernice El-
ger, University of Basel, and Thomas Gächter, University
of Zurich), Nursing Sciences (PL: Rebecca Spirig,
University Hospital Zurich), Health Services Research I
(PL: Dragana Radovanovic, University of Zurich), and
Health Services Research II (PL: Bernard Burnand and
John-Paul Vader, University of Lausanne).
Methods
Framing the project systematically: an ethical matrix
for identifying the ethical implications of DRG-based
systems
Our literature reviews for the overall IDoC project indic-
ated that no attempt had been made to systematically assess
the major ethical issues associated with DRGs or other cost
containment measures. In order to ultimately develop tools
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to assess the potentially significant impact of cost contain-
ment measures in healthcare on a number of ethically relev-
ant issues, one of our central joint results of the IDoC pro-
ject was the development of an ethical matrix that frames
the IDoC project [17]. As we have chosen the example of
DRGs in Switzerland as our primary research focus, the
matrix was generated by reviewing the literature on DRGs
and collecting empirical data, and by analysing and assess-
ing literature on ethical frameworks in public health and
clinical ethics. The matrix helps us to situate our own re-
search questions in a framework at various levels of the
health care system in order to understand how our research
can contribute to determining the impact that DRGs have
on ethically relevant factors (table 1). The matrix has been
explicitly formulated in such a way that it could be adap-
ted for assessing other cost containment measures in other
contexts.
Individual study designs
The focus of this paper is to present the first joint results
and the overall recommendations of the IDoC project.
However, in order to understand the joint results better, the
aims and methodologies associated with each sub-project
can be briefly described as follows:
Sub-project A: DRGs and changes in healthcare: an
analysis of the ethical issues and their perception by
physicians (Area: Medical Ethics)
The aim of Sub-project A was to determine which ethical
concerns physicians perceived or expected, and in which
way they attributed these changes to DRGs. Examples of
these concerns are conflicts of interest, perceived limit-
ations to professional autonomy, observed discrepancies
between physicians’ ethical standards and real life practice,
and expected implications for work motivation and job sat-
isfaction. We conducted two quantitative studies among
physicians working in Swiss hospitals for acute care [23].
The first consisted of an online questionnaire at the end of
2011 (n = 776); the second was a paper-and-pencil ques-
tionnaire in the summer of 2013 (n = 382). The benefit
of the surveys was twofold: firstly, we wanted to generate
empirical data on the status quo. As the second study was
performed after the introduction of DRGs, an early pre-
post comparison was possible, but was not our primary
aim. Due to the short time span we did not expect major
changes, but wanted to lay the basis for future follow-up
studies. Secondly, and more importantly, the design of the
questionnaires and the method of distribution were inten-
ded to help develop a survey tool for monitoring the impact
Table 1: Matrix for identifying the ethical implications of the implementation of DRGs. Reprinted from Fourie C, Biller-Andorno N, Wild V. Systematically evaluating the
impact of diagnosis-related groups (DRGs) on health care delivery: a matrix of ethical implications. Health Policy. 2014;115(2-3):157-64, with permission from Elsevier.
3. Examples1. Value/s 2. DRG-specific factors
Macro-level Meso-level Micro-level
Effects of DRGs on primary
ethically relevant parameters:
i. Utility Cost & efficiency (D) Do DRGs help to contain
costs for the healthcare system?
(D) Is efficiency under DRGs
correlated with the kind of
hospital providing the service?
(M) What, if anything, can we
learn about the impact of DRGs
from HCPs’ perceptions of
efficiency?
ii. Producing benefits Quality of care (N, M) How should we define
and measure good quality of
healthcare?
(D) How is patient safety
affected by the implementation
of DRGs at specific hospitals?
(D) How, if at all, do DRGs
influence the quality of care for
individual patients?
iii. Distributive justice Access to healthcare (N) Is sufficient access to health
care a fundamental requirement
of justice?
(D) Does the implementation of
DRGs affect access to care at
specific hospitals?
(D) What are HCPs’ perceptions
of how vulnerable groups are
affected by DRGs?
iv. Transparency Hospital transparency (D) Do DRGs result in greater
pricing transparency?
(D) Are the procedures in place
at specific hospitals conducive to
promoting transparency?
(M) How, if at all, can hospital
transparency be judged at a
micro-level?
v. Autonomy Patient autonomy (N, M) What is patient autonomy
and how should it be measured?
(D) Do DRGs lead to greater
competition between specific
hospitals and does this impact
on patient choice?
(D) How, if at all, does the
implementation of DRGs affect
the autonomy of individual
patients, e.g. through an impact
on informed consent?
Effects of DRGs on secondary
ethically relevant parameters:
vi. Professionalism (and links to
above values)
Adherence to ethical standards (N) Which ethical obligations
should be contained in HCPs’
professional standards?
(D) Have hospitals adapted their
policies on professionalism in
response to the implementation
of DRGs?
(D, N) Does cost containment
cause conflict with the
professional standards of
HCPs?
vii. (Potential links to above
values)
Work environment& job
satisfaction
(N, M) What impact, if any, does
HCPs’ job satisfaction have on
the primary parameters?
(D) Which procedures, if any, do
hospitals have in place for
counter-acting any effects that
DRGs could have on workload?
(D) How do DRGs influence
HCPs’ perceptions of workload
and job satisfaction?
Ethics of DRG-related decision-
making procedures:
viii. Procedural justice The fairness of the procedures
of health care reform
(D, N) Did the processes leading
to DRG-based health care
reform comply with ‘public
accountability’?
[Not applicable at a meso-level] [Not applicable at a micro-level]
D = descriptive; M = methodological; N = normative; HCP = healthcare practitioner
Note: The questions in the individual cells are of exemplary character, and do not represent the spectrum of questions that could be asked.
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of DRGs (or other cost containment measures) on profes-
sional practice in the future.
Sub-project B: DRGs in Switzerland: critical analysis of
the legal aspects and their perception by experts and
hospital managers (Area: Law & Ethics)
Sub-project B aimed to (1.) analyse the legal changes as-
sociated with DRGs and (2.) to evaluate whether and how
the changes associated with the Swiss-wide implementa-
tion of DRGs affected the attitude of hospital managers and
experts in hospitals. In the first part, the following legal
questions relevant to the introduction of DRGs were ex-
amined according to the themes of rationing and discrimin-
ation. Do DRGs create a form of more or less visible ration-
ing? How much control do experts have for ensuring just
and equal access to healthcare? The second, empirical part
aimed at studying the impact of the new legal instruments
(duty to admit all patients, acute and transitional care) on
hospital decision making, especially with respect to the
risk of discrimination and rationing, and at describing and
analysing expectations and fears. The sample consisted of
hospital directors and persons responsible for quality, cod-
ing, finance, and medicine controlling (n = 43). The qual-
itative interviews were conducted in 2012 in 24 cantons
of Switzerland, resulting in 11 interviews in French- and
Italian-speaking Switzerland and 32 interviews in German-
speaking Switzerland [24–27]. Qualitative content analysis
was used for the interpretation of the text material (1,708
quotations, 531 pages, 215,547 words) and was carried out
according to Mayring [28, 29].
Sub-project C: Monitoring the impact of the DRG payment
system on the nursing service context factors in Swiss
hospitals (Area: Nursing Sciences)
Sub-project C examined nursing service context factors,
such as the complexity of nursing care or leadership, which
influence nursing-sensitive patient outcomes. First, empir-
ical data on the status quo was gathered and second a con-
ceptual model and tool for the future monitoring of DRGs
was further developed. The study was a cross-sectional sur-
vey and not designed as a pre-post comparison; we are aim-
ing for a longitudinal analysis through future comparative
studies.
The study – a mixed methods design in the form of a
sequential explanatory strategy – was conducted at three
University Hospitals and two Cantonal Hospitals prior to
DRG-introduction [44]. With a set of questionnaires we
evaluated the quality of the work environment, leadership,
moral distress, job satisfaction, and nursing performance
[30–35, 45]. Our sample consisted of 5156 Registered
Nurses (RNs) and clinical nurse specialists, as well as the
unit managers from 204 inpatient units. Additional per-
sonnel and patient-related data such as grade mix, nurse
turnover, workload, complexity of nursing care, average
length of stay and nursing-sensitive patient outcomes were
obtained from other electronic sources of information. The
results were analysed by means of descriptive and inferen-
tial statistics.
Additionally, we conducted 32 focus group interviews in
2012. The sample consisted of 224 RNs, clinical nurse
practitioners involved in direct patient care and unit man-
agers of the five hospitals. The data of the focus group in-
terviews was analysed through knowledge maps and con-
tent analysis according to Mayring [28].
The outcome of our study is an improved monitoring model
based on the results of this first cross-sectional survey as
well as the further development of a set of instruments and
performance metrics. Nurse leaders and professional de-
velopment initiatives will benefit from the data generated,
providing a basis for discussions and for measures taken to
ensure quality of care and to support practice development.
Sub-project D: The impact of the implementation of the
DRG system in Switzerland on evidence-based treatment
of patients with acute myocardial infarction (Area: Health
Services Research I)
The aim of the sub-project was to assess the quality of
evidence-based treatment for acute myocardial infarction
(AMI) patients one year before and one year after the in-
troduction of the Swiss DRG system. For this purpose we
designed a measurement set using clinical data independ-
ent from administrative coded data that are linked to the
coding guidelines and regulations of the DRGs themselves
[36]. All hospitals participating in the AMIS Plus4 registry
in both years 2011 and 2012 were selected, and patients
presenting with an AMI diagnosis within the first 24 hours
of symptoms onset were included.
We measured ten items from the patient’s symptom onset
until hospital discharge as indicators for adherence to treat-
ment guidelines. Secondary endpoints were the in-hospital
outcomes (mortality, complications, length of hospital stay)
and access to healthcare for clinically vulnerable popula-
tions defined before the start of the study. Vulnerable pa-
tient groups were defined based on literature and available
records in the AMIS Plus registry, and included patients
with advanced age, female gender, co-morbidities, or AMI
related cardiac insufficiency at admission defined with Kil-
lip classes 3 or 4 [37–40].
“SAMI-Q” (Swiss Acute Myocardial Infarction and Qual-
ity), the resulting tool from our subproject combines three
types of measurements: the quality of the delivered treat-
ment; the quality in terms of in-hospital outcomes with the
measurement of the mortality rate, the percentage of major
adverse cardiac and cardiovascular events, and the length
of hospital stay in days; access to care and in-hospital out-
comes of clinically vulnerable patients.
Sub-project E: Developing and refining indicators to
measure the impact on patient safety of generalised use of
DRGs for hospital reimbursement in Switzerland (Area:
Health Services Research II)
The aim of sub-project E was to evaluate potential changes
in patient safety related to the introduction of DRGs by
means of patient safety indicators (PSI) based on routinely
collected data. Intermediate objectives were to: (1.) assess
the accuracy of a subset of PSI algorithms in one university
hospital, using the information collected in medical charts;
(2.) assess the accuracy of some PSIs against other ref-
erence standards (e.g. existing indicators); (3.) document
and investigate the frequency, variations and potential bi-
ases of PSI, using hospital discharge data collected by the
Swiss Federal Statistical Office (Hospitals Medical Statist-
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ics); (4.) evaluate trends in PSI for Swiss hospitals for the
years 2008–2014.
The seven PSI selected for this study were: decubitus ulcer,
bloodstream infection related to vascular catheter, post-
operative physiological and metabolic disorders, post-oper-
ative deep vein thrombosis and pulmonary embolism (VTE
– venous thrombo-embolism), post-operative sepsis, and
obstetric trauma during vaginal delivery with/without in-
strument.
The seven ICD-10 PSI were based on a framework al-
gorithm (table 2).
These individual algorithms for the different PSIs can be
used to follow the evolution of the impact of the use of
DRGs, but also any system-wide changes with the potential
to affect patient safety.
In summary, the IDoC project examined the perspective of
healthcare professionals (Sub-projects A and C), the per-
spective of hospital managers and administrative person-
nel (Sub-project B), the impact on the adherence to clin-
ical guidelines (Sub-project D), and the impact on Patient
Safety Indicators (Sub-project E).
Joint results
The IDoC project intended to reach an advanced level of
data interpretation that would go beyond what each group
was capable of individually. As stated above, an explicit
aim was to benefit from the resulting synergies of differ-
ent disciplines. A continuous exchange between the groups
was therefore necessary. The joint results and recommend-
ations were developed during six workshops [41], various
telephone conferences, and bilateral meetings held by the
IDoC group.
First, we can claim our systematic matrix (see table 1) as
one of our major joint results. We started developing this
matrix from the beginning of the project as a methodolo-
gical and ethical frame for our research. However, it is also
a joint result in the sense that is has evolved over the course
of the project, profiting from the group discussions.
Secondly, we are in the process of developing a more com-
prehensive “package” of tools for future use in the quality
management of hospitals. The quantitative and qualitative
studies developed by each group in fact represent elements
of these tools. More collaborative work is, however, neces-
sary to bring these methods together and to provide val-
id and effective tools that can be used outside the research
context.
Third, central themes have emerged, which affected every
discipline involved to different degrees and which were
discussed by the IDoC group. These areas include (I) the
quality and safety of patient care, (II) the state of profes-
sional practice for nurses and physicians, (III) changes in
incentives structure, (IV) vulnerable groups and access to
healthcare services. This list is not meant to present a struc-
tured or comprehensive list; instead, it indicates the recur-
Table 2: Framework algorithm as base for the seven ICD-10 PSIs.
PSI = (secondary diagnosis codes corresponding to the clinical
definition of the selected PSI) / (population at risk defined by DRG
codes, principal diagnosis codes, secondary diagnosis codes,
procedure codes)
ring and ethically significant topics which were not con-
fined to one or two disciplines. We discuss these topics in
greater detail below.
Emerging central themes
The quality and safety of patient care in general
A general answer as to whether quality of care has changed
after the introduction of DRGs is, at this stage, not possible.
Even in the future it may not be possible to answer this
question on a general level for several reasons:
First, at this stage our study cannot detect any major
changes in quality of care as DRGs have only recently
been introduced Swiss-wide. Long-term effects on quality
of care can only be identified if the monitoring of quality
of care continues over the next years and decades. It will
therefore be of crucial importance to continue the monitor-
ing of quality of care.
Secondly, a general assessment of quality of care will fail
to provide differentiated answers. A crucial result of our
study is that quality of care needs a nuanced definition and
understanding. Only once we have such an understanding
can different aspects of quality of care be evaluated. On the
one hand, such a differentiated assessment would need to
look at “hard data”, such as measurable clinical indicators
like patient mortality or infection rates. On the other hand,
soft or indirectly related factors such as quality of nursing
care, time for patient-physician interaction, teamwork, and
the education of healthcare professionals also need to be
taken into account for a more differentiated assessment of
quality of patient care.
A third issue is the difficulty of causal attribution of
changes in quality to a specific intervention such as the in-
troduction of DRG-based reimbursement. If changes do oc-
cur in the quality of care, it is very difficult to determine
whether a particular intervention is responsible for that
change. For this reason, we consider the perceptions of
healthcare professionals, who have first-hand experience
with DRGs as well as with other reimbursement systems,
to be of particular importance as they may point to causal
relationships that merit further scrutiny. However, the per-
ceptions could also be related to other changes in health-
care such as increasing competition between hospitals or
increasing transparency, and not explicitly to DRGs. Future
quality assessments that try to link certain changes in qual-
ity to certain reimbursement systems will have to deal with
the problem of causal attributions.
Specific answers to determining the quality and safety of
patient care
For a more nuanced understanding of quality and safety of
patient care it could be promising to try to identify “hot
spots”, i.e. specific ethically problematic areas related to
the increased emphasis on cost containment and to try to
monitor and assess these in relation to quality of care. Ac-
cording to our experiences within the IDoC project, “hot
spots” include for example: insufficient quality manage-
ment (A), the existence of over- and under-treatment as a
result of the incentives inherent in DRGs (A), less time for
communication with patients, relatives and within the care
team (A), more time for administration (A), limitations to
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realising important professional principles in daily practice
that may influence quality of medical care (A), the exist-
ence of case splitting (A), a decrease in “patient-oriented
care” (A), the delay or cancellation of necessary patient
care provided by nurses (C), worse in-hospital outcomes
for some “vulnerable patient groups” (D), inadequate col-
laboration with home care, long-term inpatient care and re-
habilitation clinics (B), omission of treatment for which
success is estimated to be low (B), and the problem of cost
reduction, for example in laboratories, without risking pa-
tient safety (B). It will be important to identify further “hot
spots”, but also to monitor and assess the intended positive
changes of DRGs, such as the following in order to reach a
balanced evaluation of changes in healthcare.
Possible improvements related to the introduction of DRGs
were for example: earlier discharge without a reduction of
adherence to clinical guidelines or worse outcome (D, B),
quality leap due to more accurate processes (B), an increase
in process quality and patient safety due to standardised pa-
tient pathways (B), better functioning of hospital informa-
tion systems with the possibility to access important data
quickly and safely (B), improved possibilities for working
towards structural reforms as it is easier to see where med-
ical priorities need to be set and where hospitals should in-
vest (B), and a concentration on certain areas of clinical ex-
pertise which helps to reduce costs and at the same time to
reach a critical mass per intervention allowing good quality
(B).
In the attempt to capture quality in a more nuanced way,
IDoC also encountered various methodological challenges
e.g. in relation to the collection of data or the permission
to access certain databases or study groups. Future assess-
ments will have to deal with such constraints. As an ex-
ample we had to work with a (previously known) delay in
accessing the official source data from the Federal Office
of Statistics (more than 2 years after the index year) (E), the
lack of possibility to follow hospitals from year to year, be-
cause the data is anonymised and the anonymised identity
is changed from year to year (E), and a lack of resources
for validating PSI using a chart review of medical records,
including the cost for collecting data, and for obtaining ap-
propriate sampling from various hospitals (E).
The state of professional practice for nurses and
physicians
Our research indicates that in Switzerland job satisfaction
among nurses and physicians is high. However, the parti-
cipants report a number of problems related to the adher-
ence to professional ethos and to their working conditions.
Whether and how they are related to DRGs is difficult to
assess, given the complexity of the healthcare reform in
Switzerland. At this point we can only rely on the subject-
ive attribution of these experiences to the introduction of
DRGs.
The problems detected by the IDoC project include: the de-
terioration of the work satisfaction of physicians attributed
to SwissDRG (A), difficulty for physicians to implement
professional principles – such as focusing on the wellbeing
of the patient, respecting patient preferences, and having
sufficient time for patients – under current working condi-
tions (A), less time for their own training and continuing
education and that of young colleagues since the new hos-
pital reform (A), an increase in the multi-morbidity of pa-
tients and a growing complexity of care that needs to be
met by adequate nursing staff (C), experience of moral dis-
tress among nurses (C), and the intention of some physi-
cians and nurses to leave their jobs or reduce work hours
(A, C).
Changes in incentives structure
Another recurring topic in our joint discussions was the
ways in which cost containment instruments can incentiv-
ise behaviour. Before the introduction of DRGs in Switzer-
land many hospitals were reimbursed according to day
rates. At that time physicians were incentivised to keep pa-
tients longer than necessary. According to the interviews
with hospital managers and legal experts (B), the imple-
mentation of SwissDRG has changed the incentive struc-
tures in various ways, namely with respect to a decreased
length of stay, more efficient use of resources and higher
productivity, general cost awareness, improvement of the
quality of treatments, structures, processes, and increased
transparency.
However, we also found examples of ways in which DRGs
may be incentivising behaviour that raises concerns: case
splitting, unnecessary care, rationing of medical services,
unnecessary hospital admissions if outpatient care is also
possible, and keeping patients in hospital longer than ne-
cessary because the minimum length of stay was not
reached (A) as well as a reduction of medical training activ-
ities and misdirected incentives resulting in disadvantages
for vulnerable groups [24].
In the area of nursing, we found that DRGs can incentivise
the reduction of nursing interventions when they are in
competition with interventions required immediately by the
patient or with interventions ordered by physicians (C). Fo-
cus group interviews showed how the failure to carry out
nursing interventions can have consequences for patients
and for nurses (C). It was reported that adverse events such
as patient falls or pressure ulcers occur more often in these
situations. In addition, recovery time is lengthened and it
can take longer for patients to reach the desired level of
self-care and self-management. Our studies have shown
that this inadequate setting of priorities can lead to nurses
experiencing feelings of guilt, moral distress, dissatisfac-
tion, frustration, and even anxiety [35].
Even though we detected problems with the incentives in-
herent in DRGs, we believe that most, if not any, altern-
ative hospital reimbursement system brings with it incent-
ives. The challenge is to monitor the effects of any incent-
ive system and to compare them to alternative strategies for
containing costs in healthcare.
Vulnerable groups and access to healthcare services
Another recurring topic was the “vulnerability” of patient
groups. Firstly, we found it difficult to define vulnerability
in the context of DRGs and secondly, it was a methodolo-
gical challenge to prove that vulnerable groups have been
affected. In the literature there has been a large amount of
speculation in terms of which groups might be vulnerable
under a DRG-based system. Although very little empiric-
al data is available up till now, we can cautiously draw
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some general results regarding DRG-related vulnerability
in Switzerland.
Fair and appropriate access to healthcare is required by
Swiss law. Ensuring access is primarily an issue of social,
fiscal, or health policy that should be defined by policy
makers. “Vulnerable groups” within the Swiss DRG system
can be defined in two ways. There are pre-defined groups,
mostly based on social characteristics, such as migrants,
poor patients and patients without family or other social
networks, who are at risk of suffering disadvantages in the
DRG system. A second definition is also required in order
not to miss certain vulnerable persons who do not fit such
predefined categories. As part of that definition, groups
that are vulnerable in the DRG system are defined post
hoc, which means patients for whom refunding is not prop-
erly represented within the tariff structure which has been
agreed upon with the Swiss cantons. However, according
to hospital experts, this problem is mostly passed on to
the individual healthcare service providers, and no solution
has been provided at the more general cantonal level (B).
Hospitals are currently trying to negotiate the refunding of
these groups. If the cantons accept the “vulnerability” of
these groups and the importance of refunding them, addi-
tional support can be negotiated between hospitals and can-
tons. This could help to at least partially address discrim-
ination in care for vulnerable groups. Efforts of hospitals
to obtain certifications like, for example, “migrant friendly
hospital”, can contribute to strengthening the awareness to
keep entrance thresholds low. Especially public hospitals
stress their mandate to guarantee access to healthcare ser-
vices to all patients groups at all times and avoid selective
treatments [25].
Discussion
The IDoC project aimed to identify systematically the eth-
ically relevant issues related to the implementation of
DRGs. As a project funded as part of the Sinergia pro-
gramme of the Swiss National Science Foundation, IDoC
has been working on two levels over the course of three
years of research. On the individual level, sub-projects
have conducted independent research, and specific results
have been provided in each of the different disciplines. Ad-
ditionally, IDoC has functioned synergistically, identifying
recurring themes, discussed in the previous section. Given
that DRGs affect the macro-, meso- and micro-level of the
healthcare system and are perceived differently from vari-
ous perspectives, such a collaborative effort was the appro-
priate strategy for addressing the research topic.
Our project can serve as a preliminary model for future
more comprehensive and systematic research on the effects
of DRGs or other provider payment systems. The ethical
matrix is particularly significant in terms of being able to
structure research within an ethical context. While the mat-
rix was developed in light of the Swiss healthcare reform,
it can also be used as a basis for identifying the ethical im-
plications of DRG-based systems in other countries and for
highlighting the ethical implications of other kinds of pay-
ment provider systems. As healthcare reforms and the in-
troduction of cost containment instruments are usually not
systematically assessed from an ethical point of view and
there is a lack of guidance in the literature, our project can
be seen as one of the first attempts to model such an as-
sessment. The success of the assessment depends on vari-
ous factors, such as starting to plan early enough in order
to gather before-and-after-data adequately and to build up
functioning interdisciplinary networks further, as well as
being aware of and meeting the array of methodological
problems that come with such a complex project. So far,
IDoC has only been able to work with pre- or early-imple-
mentation data. More analyses will be needed as post-im-
plementation data become available.
Some important limitations of our project should be men-
tioned. The first one is the lack of more relevant empirical
information on healthcare quality and access in Switzer-
land long before the introduction of DRGs. There is in-
sufficient data, for example, on access, vulnerable groups,
disease management, ethos of healthcare professionals, in
order to make precise pre-post comparisons. For example,
our surveys of nurses and physicians aimed primarily at
providing data on the status quo and cannot be compared to
data in the past (as it does not exist) but at least could and
should be compared to future data in order to measure and
monitor nurses and physicians’ perceptions of professional
practice on a long-term basis.
Secondly, any changes found before and after 2012 cannot
be solely attributed to the introduction of DRGs. A number
of adaptations occurred along with SwissDRG, among
them a new regulation of cost-sharing between cantons and
insurers, the creation of a single hospital market with free
choice of hospital, the guarantee of entrepreneurial free-
dom and the safe-guarding of quality (Botschaft betreffend
die Änderung des Bundesgesetzes über die Krankenver-
sicherung: BBl 2004 5551, 5564). It will remain difficult,
if not impossible to settle on clear causal relations between
the introduction of isolated measures in healthcare reform
(such as DRGs) and surveyed changes, but it will be pos-
sible to ask professionals whether they attribute changes to
a certain measure. This can serve at least as a signpost for
potentially problematic areas.
A final limitation is the lack of additional perspectives, for
example, those of patients. It would have been an asset to
the international literature and to our project specifically
to survey patients’ experiences before and after the im-
plementation of DRGs, and this perspective should be in-
cluded in future studies. It will also be of interest to link
results with economic issues in the future, for instance to
cost shifting between inpatient and rehabilitative care.
Conclusion
In this paper we have given an overview of the IDoC pro-
ject in Switzerland. We have described the advantages and
limitations of our pioneering attempt to systematically as-
sess and monitor ethically relevant changes in healthcare
after the introduction of DRGs in Switzerland. As has be-
come clear, this endeavour is a complex process and only
in its beginning stages, not only in Switzerland, but world-
wide. More concrete guidance on the situation in Switzer-
land can be given only once possible pre-post changes can
be more fully captured a few years into the implementation
of DRGs. Still, it has already become apparent that there
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are various future activities needed in the field, which we
briefly sketch as a conclusion:
Conceptual analysis: From our point of view, some con-
cepts related to DRGs deserve closer analysis. For ex-
ample, effects on the “quality of patient care” are fre-
quently discussed in health economics, healthcare system
research, and ethics. However, it is not clear, what exactly
falls under “quality of patient care”. As we have explained,
effects can range from very obvious ones, e.g. on patient
mortality, to much more subtle effects for example on the
quality of interaction between healthcare professionals and
patients. To capture these effects, a nuanced, comprehens-
ive understanding of quality is necessary.
Methodological refinement: So far the methods for com-
prehensively assessing the impact of DRGs are not suffi-
cient in any country. In the IDoC project we have made
an effort to jointly develop methodological tools that cap-
ture more fine-grained aspects of the quality of healthcare.
These tools were piloted during our studies and can, once
they have been further refined and validated, enrich the
instruments already available for assessing the quality of
care. However, further joint efforts, also on an international
level, are necessary to enhance such methods. It is crucial
to plan an assessment of changes in healthcare according
to a long-term perspective, in order to capture positive and
negative effects well enough. We expect various method-
ological challenges for such a long-term assessment, such
as the problem of causal attribution, and difficulties in ac-
cessing databases or study populations. Future projects will
have to find appropriate ways to deal with such challenges.
Monitoring: Conflicts of interests caused by economic or
other non-care related considerations can affect the quality
and equity of patient care through, for example, medical
errors and other patient safety problems. However, current
monitoring still focuses on a very narrow set of indicators.
This spectrum should be broadened to include the full set of
issues that may arise from incentives introduced by DRGs
(or other reimbursement systems). In doing so, the differ-
ent dimensions of healthcare quality – e.g. safety, effective-
ness, timeliness, and efficiency as well as personalised and
equitable care [42] – should be taken into consideration.
Implementation: We need an increased effort to bridge the
gap between research on the one hand and management and
policy decisions on the other. Empirical data can provide
important feedback on governance in individual healthcare
institutions as well as at the level of national health sys-
tems. However, translating the results of academic studies
into information useful for management or policy pro-
cesses requires a targeted effort. This becomes ever more
prominent as health systems are increasingly conceived as
being “learning systems”, that is, systems that constantly
improve according to evidence and that effectively aim at
the best value for the patient [43].
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Footnotes
1 Some hospitals in Switzerland were already operating un-
der a DRG system before 2012 although January 2012 was
the first time that the new tariff structure ‘SwissDRG’ – de-
veloped from the German G-DRG – was made mandatory
for all acute-care Swiss hospitals.
2 The IDoC project has been funded by the Swiss National
Science Foundation over the course of three years from
2011–2013.
3 See also: Chapters “Emerging central themes” and “Dis-
cussion”.
4 AMIS plus registry is an ongoing observational clinical
study, registered at ClinicalTrials.gov (identifier
NCT01305785), approved by the Supra-Regional Ethics
Committee for Clinical Studies, the Swiss Board for Data
Security, and the Cantonal Ethics Commissions.
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